ACCOR SA (AC.PA)

FR0000120404 - Common Stock

37.77  -0.56 (-1.46%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
2.204B
35.97%
4.224B
91.65%
5.056B
19.70%
5.635B
11.45%
EBITDA
YoY % growth
N/A
110.14%
N/A
1,565.62%
N/A
52.04%
1.147B
12.45%
EBIT
YoY % growth
-228M
65.71%
447M
296.05%
723M
61.74%
848.9M
17.41%
Operating Margin
-10.34%10.58%14.30%15.06%
EPS
YoY % growth
-2.09
55.90%
N/A
135.33%
1.86
152.38%
2.29
23.33%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
1.48
41.26%
Revenue
Q2Q % growth
2.926B
10.17%
EBITDA
Q2Q % growth
615.94M
10.13%
EBIT
Q2Q % growth
504.7M
24.00%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
0.90
11.11%
1.17-0.27-23.35%
Q4 2023
Q2Q % growth
1.05
251.52%
1.08-0.03-3.22%
Q2 2023
Q2Q % growth
0.81
1,083.01%
0.550.2648.38%
Q4 2022
Q2Q % growth

238.29%
0.30%
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
2.677B
11.54%
2.645B32M1.21%
Q4 2023
Q2Q % growth
2.656B
6.28%
2.788B-132M-4.73%
Q2 2023
Q2Q % growth
2.4B
39.13%
2.411B-11M-0.46%
Q4 2022
Q2Q % growth
2.499B
81.09%
2.173B326M15.00%
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -1.13% -1.96%
RevenueN/A N/A 0.39% 1.46%